Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease

Journal of Clinical Investigation

Volumn 109, Issue 10, 2002, Pages 1335-1344

  Zhang, Yi ^a   Louboutin, Jean Pierre ^a   Zhu, Jiang ^a   Rivera, Adam J ^a   Emerson, Stephen G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD8 ANTIGEN; GAMMA INTERFERON; MINOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL AGGREGATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GRAFT VERSUS HOST REACTION; HOST CELL; IRRADIATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0036099858     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0214989     Document Type: Article

References (45)

1. Pathophysiologic mechanisms of acute graft-vs.-host disease
2. Acute graft-vs.-host disease: Case: Pathobiology, and management
3. The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism
4. Identification of a graft versus host disease-associated human minor histocompatibilicy antigen
5. Characterization of naturally occurring minor hiscocompatibility peptides including H-4 and H-Y
6. Minor histocompatibility antigens: From T cell recognition to peptide identification
7. Recent advances in graft versus-host disease (GVHD) prevention
8. Variable capacicy of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice
9. Functions of purified L3T4+ and Lyt-2+ cells in vitro and in vivo
10. Dendritic cells and the control of immunity
11. Dendritic cells in transplantation - Friend or foe?
12. Prevention of graft versus host disease by inactivation of host antigen-presenting cells
13. Stimulation of mature unprimed CD8+ T cells by semiprofessional antigen-presenting cells in vivo
14. T cell contact with la antigens on nonhemopoietic cells in vivo can lead to immunity, rather than tolerance
15. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages
16. The surface phenotype of dendritic cells purified from mouse thymus and spleen: Investigation of the CD8 expression by a subpopulation of dendritic cells
17. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice
18. Graft-versus-host reactions in dermatology
19. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
20. Induction of dendritic cell differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor, and tumor necrosis factor alpha in vitro from lineage phenotypes-negative c-kit+ murine hematopoietic progenitor cells
21. Bifurcated dendritic cell differentiation in vitro from murine lineage phenotype-negative c-kit+ bone marrow hematopoietic progenitor cells
22. Graft-versus-host disease
23. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo
24. Dendritic cells efficiently cross-prime HLA class Irestricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates
25. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary, immune responses
26. Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes
27. Persistence of memory CD8 T in MHC class I-deficient mice
28. Natural adjuvants: Endogenous activators of dendritic cells
29. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation ofimmunostimulatory dendritic dendritic cells
30. The cytokine modulation of acute graft-versus-host disease
31. Pathogenesis of acute graft-versus-host disease: Cytokines and cellular effectors
32. Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation
33. Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines
34. The role of cytokines in acute graft-versus-host disease
35. Differential roles of IL-1 and TNF -alpha on graft-versus-host disease and graft versus leukemia
36. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: Rationale for the use of cytokine shields in allogeneic bone marrow transplantation
37. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas
38. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions
39. The history and future of T -cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation
40. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy
41. Graft-vs.-host and graft vs.-leukemia reactions after delayed infusions of donor T-subsets
42. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease
43. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation
44. Memory CD8+ T cell differentiation: Initial antigen encounter triggers a developmental program in naive cells
45. Intertrain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens